IRIS
GAIDANO, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.040
EU - Europa 18.573
AS - Asia 10.837
SA - Sud America 2.375
AF - Africa 331
Continente sconosciuto - Info sul continente non disponibili 73
OC - Oceania 30
Totale 51.259
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.666
IE - Irlanda 5.566
SG - Singapore 3.734
DE - Germania 2.837
HK - Hong Kong 2.720
SE - Svezia 2.676
UA - Ucraina 2.190
CN - Cina 2.062
BR - Brasile 1.894
IT - Italia 1.486
RU - Federazione Russa 1.474
FI - Finlandia 1.190
VN - Vietnam 990
GB - Regno Unito 441
IN - India 363
KR - Corea 317
CA - Canada 209
AR - Argentina 194
FR - Francia 179
ID - Indonesia 125
MX - Messico 118
ZA - Sudafrica 104
BJ - Benin 103
BD - Bangladesh 100
EC - Ecuador 84
NL - Olanda 79
PL - Polonia 76
AT - Austria 70
EU - Europa 70
JP - Giappone 70
IR - Iran 68
ES - Italia 60
TR - Turchia 58
BE - Belgio 55
CZ - Repubblica Ceca 54
CO - Colombia 50
LT - Lituania 50
IQ - Iraq 41
VE - Venezuela 41
PY - Paraguay 39
CL - Cile 28
EG - Egitto 27
PE - Perù 27
MA - Marocco 21
SY - Repubblica araba siriana 21
AU - Australia 19
KE - Kenya 18
PK - Pakistan 18
DZ - Algeria 17
UZ - Uzbekistan 16
BG - Bulgaria 15
MY - Malesia 15
RO - Romania 15
SA - Arabia Saudita 15
IL - Israele 13
UY - Uruguay 13
DO - Repubblica Dominicana 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 10
AL - Albania 9
CH - Svizzera 9
ET - Etiopia 9
JO - Giordania 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
AZ - Azerbaigian 7
KG - Kirghizistan 7
NP - Nepal 7
HN - Honduras 6
HR - Croazia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BH - Bahrain 5
RS - Serbia 5
CI - Costa d'Avorio 4
DK - Danimarca 4
JM - Giamaica 4
LB - Libano 4
MK - Macedonia 4
NG - Nigeria 4
NI - Nicaragua 4
AM - Armenia 3
AO - Angola 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
GE - Georgia 3
GR - Grecia 3
KW - Kuwait 3
LU - Lussemburgo 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
GT - Guatemala 2
Totale 51.224
Salva come PNG Salva come JPEG
Città #
Dublin 5.550
Jacksonville 3.929
Hong Kong 2.717
Dearborn 1.869
Chandler 1.333
Singapore 1.312
Wilmington 1.277
Beijing 997
Ashburn 924
Lawrence 733
Princeton 732
Moscow 609
San Mateo 564
Los Angeles 498
Andover 379
Piemonte 371
Ho Chi Minh City 366
Buffalo 365
Seoul 314
Boardman 313
Ann Arbor 301
Hanoi 203
Woodbridge 199
Houston 194
Novara 165
São Paulo 163
New York 147
Munich 143
Redondo Beach 142
Hefei 135
Dallas 132
Philadelphia 116
Düsseldorf 115
Helsinki 109
Nanjing 109
Cotonou 103
Bremen 102
Kunming 98
Norwalk 91
Grafing 80
Frankfurt am Main 76
Milan 73
Montreal 67
Toronto 64
London 63
Tokyo 62
Nuremberg 60
Brooklyn 59
Rio de Janeiro 59
Warsaw 59
Denver 57
Johannesburg 56
Chennai 54
Santa Clara 53
Seattle 53
Jinan 52
Mexico City 52
Poplar 52
Brussels 50
Fairfield 50
Stockholm 49
Atlanta 47
Turin 46
Guangzhou 45
Phoenix 43
Curitiba 42
Belo Horizonte 41
Brno 41
Tianjin 39
Chicago 38
Haiphong 37
Nanchang 37
Orem 37
Falkenstein 36
Jakarta 36
Boston 35
Brasília 35
Rome 33
Vienna 32
Mumbai 31
Da Nang 30
Porto Alegre 30
Biên Hòa 29
Turku 29
San Francisco 28
Thái Bình 28
Vercelli 28
Zanjan 28
Guayaquil 27
Manchester 27
Quito 25
Amsterdam 24
Dhaka 24
Falls Church 24
Ankara 23
Shenyang 23
Ninh Bình 22
Campinas 21
Fuzhou 21
Salvador 21
Totale 30.462
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 204
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 186
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 175
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 159
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 149
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 141
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities 138
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 138
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 138
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 129
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 129
Benefit sharing and globalisation of industry sponsored clinical trials for breast cancer research 127
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 125
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 124
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 124
The clinical implications of gene mutations in chronic lymphocytic leukaemia 123
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 122
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 121
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 120
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 119
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 115
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 113
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 113
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 112
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 112
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 112
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 110
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 109
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 107
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 106
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 106
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 106
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 105
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 105
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 104
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 103
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 103
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 103
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 102
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 102
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 102
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 101
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 101
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 101
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 101
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 101
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 101
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 100
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 100
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 100
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 99
Absence of NOTCH1 gene mutations in MALT lymphomas 99
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 99
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 99
Factor VIII as a potential player in cancer pathophysiology 99
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 98
Biology and treatment of Richter syndrome 98
MOLECULAR INVESTIGATION OF THE CYTOKINES PRODUCED BY NORMAL AND MALIGNANT B LYMPHOCYTES 97
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 97
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 97
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 96
European education corridors: opportunity for academic solidarity 96
SAC I RFLP IN THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR GENE (IGF2R) ON HUMAN CHROMOSOME 6q 95
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 95
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 95
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A 95
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 95
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 95
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 94
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 94
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 93
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 93
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 93
The genetics of nodal marginal zone lymphoma 93
ESTABLISHMENT OF AIDS-RELATED LYMPHOMA CELL LINES FROM LYMPHOMATOUS EFFUSIONS 92
HIV-ASSOCIATED HHV-8 POSITIVE PRIMARY LYMPHOMATOUS EFFUSIONS: RADIOLOGICAL FINDINGS IN SIX PATIENTS 92
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 92
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 92
Targeting p53 in chronic lymphocytic leukemia 92
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 91
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 91
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies. 91
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 91
KAPOSI's SARCOMA-ASSOCIATED HERPESVIRUS DNA SEQUENCES IN AIDS-RELATED AND AIDS-UNRELATED LYMPHOMATOUS EFFUSIONS 91
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 91
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 91
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 90
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 90
Genetic determinants of response to warfarin. 90
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 90
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 90
MOLECULAR PATHOGENESIS OF NON-HODGKIN LYMPHOMA: A CLINICAL PERSPECTIVE 89
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 89
Potential of BCL2 as a target for chronic lymphocytic leukemia treatment 89
TAQI RFLP IN THE INTERFERON GAMMA RECEPTOR 1 GENE (IFNGR1) ON HUMAN CHROMOSOME 6q 88
GROWTH- AND DIFFERENTIATION-ASSOCIATED EXPRESSION OF BCL-2 IN B-CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 88
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 88
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. 88
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 88
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 88
Totale 10.593
Salva come PNG Salva come JPEG
Categoria #
all - tutte 305.951
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 305.951
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.537 0 0 0 0 0 54 707 33 710 66 826 141
2021/20224.996 122 26 992 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20243.104 241 214 246 76 585 50 630 78 23 41 215 705
2024/20258.283 182 63 257 173 245 473 646 843 2.767 882 332 1.420
2025/202610.039 1.029 893 2.116 3.717 1.947 337 0 0 0 0 0 0
Totale 52.090